Designed by Life Sciences Experts.
ERMA was built by experienced Veeva users who deeply understand the pain points of advertising agencies, brand managers, and regulatory teams—ensuring every feature is rooted in genuine workflow improvements. We've encountered it all: cumbersome referencing, inefficient workflows, lengthy MLR review meetings, and costly delays that push back new product launches or required product updates that frustrate key stakeholders. We created ERMA—to drive REAL change in the Pharmaceutical, Biotechnology, Medical Device, Gene Therapy, and Animal Sciences sectors. Every feature of ERMA has been thoughtfully crafted based on decades of experiences and interactions with project teams from multiple life sciences companies. We've taken this real-world input and used it as the foundation of our ERMA mission and vision.
Leadership
Julia Gardner
Founder
Ray Hwang
CTO
Paul Kania
CFO
Tyler Chen
Tech Operations Lead
Our Advisory Board
The ERMA team and its advisory board have the right skill set and experience to turn this into a successful story
Israel Aker
Senior Manager, Medical Writing & Promotional Review at the PPD™ clinical research business of Thermo Fisher Scientific
Registered Clinical Pharmacist with 20+ years across clinical and industry settings with experience in Pharmacy & Therapeutics, drug safety and pharmacovigilance, medical affairs, and medical writing. Currently serving as Senior Manager, Medical Writing & Promotional Review at Thermo Fisher Scientific.
Ilze Kurins Antons
Founder & Principal
Kurins Consulting, LLC
Kurins Consulting, LLC
Over three decades of Regulatory Affairs experience in a variety of Pharmaceutical and Biotech companies. Now providing consulting services for advertising and promotion for the pharmaceutical industry.
Christine Hendrick
Director, Commercial Services,
Acadia Pharmaceuticals, Inc.
Acadia Pharmaceuticals, Inc.
Former lead of Marketing Operations
at Zogenix, Recordati Rare Diseases,
and Lundbeck.
Jaime Melendez
Strategic Operations, Research
and Product Development, CSL
and Product Development, CSL
Former Director, Emerging Technology Partnership and Innovation at Johnson & Johnson. Additionally, Associate Director, Technology Partnership and Business Development at Merck.
Brandon Schlette
Associate Director of Commercial Operations, Recordati Rare Diseases
Associate Director of Commercial Operations at Recordati Rare Diseases of North America with nearly a decade of experience in the pharmaceutical industry. Specializing in workflow-based software, commercial operations initiatives, with a proven track record of managing complex projects and enhancing operational efficiency. Highly proficient in navigating regulatory environments and optimizing marketing operations, evidenced by successful leadership in corporate & marketing processes.
Arvind Sreedharan
Sr. VP, Business Operations,
Neurogene Inc.
Neurogene Inc.
Three decades of commercial experience. Former VP, of U.S. Commercial Operations for AveXis, the company that developed Zolgensma®, an FDA-approved treatment for spinal muscular atrophy; acquired by Novartis for $8.7 billion.
